Cardiac ryanodine receptor phosphorylation: target sites and functional consequences
about
Patient Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Development and Screening In Catecholaminergic Polymorphic Ventricular TachycardiaModeling Catecholaminergic Polymorphic Ventricular Tachycardia using Induced Pluripotent Stem Cell-derived Cardiomyocytes.Electrophysiological remodeling in heart failureExogenous expression of human apoA-I enhances cardiac differentiation of pluripotent stem cells.Mapping the ryanodine receptor FK506-binding protein subunit using fluorescence resonance energy transfer.Epac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart.Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes.Cardiomyocyte Ca2+ handling and structure is regulated by degree and duration of mechanical load variation.Signalosomes as Therapeutic Targets.Ryanodine receptor-mediated arrhythmias and sudden cardiac death.Regulation of cardiac excitation and contraction by p21 activated kinase-1Loss of proteostatic control as a substrate for atrial fibrillation: a novel target for upstream therapy by heat shock proteinsmAKAP-a master scaffold for cardiac remodeling.Murine Electrophysiological Models of Cardiac Arrhythmogenesis.Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-type calcium channelsFunction of the CaMKII-ryanodine receptor signaling pathway in rabbits with left ventricular hypertrophy and triggered ventricular arrhythmia.Ca(2+) wave probability is determined by the balance between SERCA2-dependent Ca(2+) reuptake and threshold SR Ca(2+) content.
P2860
Q28067569-7BC47CC8-1282-4BA4-AB9D-5AF3A7273DCDQ33163102-94B82354-41FD-41F3-8761-8EC022AE2856Q33887264-E7C495D3-8BFC-40A3-B231-FB82AA6FEAC4Q33904083-DA2E5A47-F673-4F43-A72A-D07DC3BADE08Q33911293-22F69CF1-4F8E-4ACF-91AD-3476D65675CFQ34792255-339A4AB8-C2A5-48DC-9B96-4176CD223C77Q35140062-A67D1082-34DE-4100-BD98-92FE5A48FC11Q35370217-6C3660E9-B657-444B-8639-C5930953FAFDQ36666473-DC101808-CFA7-469E-9F6D-191978064B60Q37248371-0DA7825F-0DE6-4119-9D55-F8A1BAE36DB4Q37259560-E287BFF7-3DAA-440E-AD5F-C9BC288DE90AQ37989142-A9DCC769-2378-44D4-84C7-20856A1952B9Q38304614-CAA771DC-5E55-4026-BD48-E6FE7BE16BBFQ39038606-C6FD91D5-4335-4081-A6BB-97119B705FE9Q41835572-CD1A2681-080E-4472-94FA-ED40054E86C1Q41970056-286A398A-87CA-460B-90CD-F890EC18752FQ51612393-58A5824C-16B0-4AF8-8BD8-D9D382E13554
P2860
Cardiac ryanodine receptor phosphorylation: target sites and functional consequences
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Cardiac ryanodine receptor phosphorylation: target sites and functional consequences
@ast
Cardiac ryanodine receptor phosphorylation: target sites and functional consequences
@en
type
label
Cardiac ryanodine receptor phosphorylation: target sites and functional consequences
@ast
Cardiac ryanodine receptor phosphorylation: target sites and functional consequences
@en
prefLabel
Cardiac ryanodine receptor phosphorylation: target sites and functional consequences
@ast
Cardiac ryanodine receptor phosphorylation: target sites and functional consequences
@en
P2860
P356
P1433
P1476
Cardiac ryanodine receptor phosphorylation: target sites and functional consequences
@en
P2093
Donald M Bers
P2860
P356
10.1042/BJ20060377
P407
P577
2006-05-01T00:00:00Z